NYSE: UHSUniversal Health Services Inc Stock
$157.47+3.82 (+2.49%)
Updated Apr 19, 2024
UHS Price
$157.47
Fair Value Price
N/A
Market Cap
$10.59B
52 Week Low
$119.90
52 Week High
$183.61
P/E
15.21x
P/B
1.72x
P/S
0.74x
PEG
1.07x
Dividend Yield
0.51%
Revenue
$14.28B
Earnings
$717.80M
Gross Margin
100%
Operating Margin
8.02%
Profit Margin
5%
Debt to Equity
1.26
Operating Cash Flow
$1B
Beta
1.12
Next Earnings
Apr 25, 2024
Ex-Dividend
N/A
Next Dividend
N/A
UHS Overview
Universal Health Services, Inc. operates acute care hospitals, and outpatient and behavioral health care facilities. As of 2022/2/24, the company owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states. The company also provides commercial health insurance services and management services (purchasing,finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations). UHS was founded in 1978 and is headquartered in King of Prussia, PA.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how UHS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
UHS ($157.47) is trading above its intrinsic value of $108.21, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
UHS is good value based on its earnings relative to its share price (15.21x), compared to the US market average (40.51x)
P/E vs Market Valuation
UHS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more UHS due diligence checks available for Premium users.
Be the first to know about important UHS news, forecast changes, insider trades & much more!
UHS News
Valuation
UHS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
15.21x
Industry
-2.45x
Market
40.51x
UHS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
UHS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
UHS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.72x
Industry
4.44x
UHS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
UHS price to earnings growth (PEG)
For valuing profitable companies with growth potential
UHS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
UHS's financial health
Profit margin
Revenue
$3.7B
Net Income
$216.4M
Profit Margin
5.8%
UHS's Earnings (EBIT) of $1.15B... subscribe to Premium to read more.
Interest Coverage Financials
UHS's profit margin (5%) has... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$14.0B
Liabilities
$7.8B
Debt to equity
1.26
UHS's short-term assets ($2.81B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
UHS's long-term liabilities ($5.76B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
UHS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
UHS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$452.4M
Investing
-$238.8M
Financing
-$182.3M
UHS's operating cash flow ($1.27B)... subscribe to Premium to read more.
Debt Coverage Financials
UHS vs Medical Care Facility Stocks
Universal Health Services Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.